While the improved survival of patients with increased expression of FOXP3 or IDO1 contradicts the role of T-cell suppression in cervical cancer, FOXP3 and IDO1 can be expressed in tumor cells [45,46]. This evidence concerns the gene IDO1 and cervical carcinoma.